Publication | Open Access
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR
34
Citations
28
References
2020
Year
Although larger studies are necessary to confirm and further explore this tracer, we describe the promising performance of [<sup>18</sup>F]PARPi as a diagnostic tool to evaluate patients with brain cancers and possible treatment-related changes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1